Evidence map›Paper›PMID 33712056›Full record

ArticleDiagnostic pathology2021

Sialadenoma papilliferum: clinicopathologic, Immunohistochemical, molecular analyses of new five cases and review of the literature.

Shuai Chen, Jie Peng, Chuantao Yuan, Lin Sun, Renya Zhang, Yan Sun

Open access · goldAbstract read
In one paragraph

Article in Diagnostic pathology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Sialadenoma Papilliferum: An Uncommon Verruco-Papillary Lesion of the Oral Cavity.Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India · 2025
    Article
  6. Article
  7. Article
  8. Low-grade non-intestinal-type sinonasal adenocarcinoma: a histologically distinctive but molecularly heterogeneous entity.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2022
    Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Shuai ChenDepartment of Pathology; Key Laboratory of Cancer Prevention and Therapy; Tianjin's Clinical Research Center for Cancer; National Clinical Research Center for Cancer, Tianjin Cancer Institute and Hospital, Tianjin Medical University, Tianjin, PR China.
Jie PengDepartment of Pathology, Affiliated Hospital of Jining Medical University, Jining, Shandong Province, PR China.
Chuantao YuanDepartment of Pathology, Affiliated Hospital of Jining Medical University, Jining, Shandong Province, PR China.
Lin SunDepartment of Pathology; Key Laboratory of Cancer Prevention and Therapy; Tianjin's Clinical Research Center for Cancer; National Clinical Research Center for Cancer, Tianjin Cancer Institute and Hospital, Tianjin Medical University, Tianjin, PR China.
Renya ZhangDepartment of Pathology, Affiliated Hospital of Jining Medical University, Jining, Shandong Province, PR China. zhangrenya@mail.jnmc.edu.cn.
Yan SunDepartment of Pathology; Key Laboratory of Cancer Prevention and Therapy; Tianjin's Clinical Research Center for Cancer; National Clinical Research Center for Cancer, Tianjin Cancer Institute and Hospital, Tianjin Medical University, Tianjin, PR China. yansun781028@163.com.ORCID https://orcid.org/0000-0001-8916-9598
Tianjin Medical University Cancer Institute and Hospital · CNAffiliated Hospital of Jining Medical University · CNCentral Hospital of Zibo · CN

Funding

National Natural Science Foundation of China 81472263National Natural Science Foundation of China 81871990
6 · The paper itself

Abstract

backgroundSialadenoma papilliferum (SP) is an extremely rare benign neoplasm of salivary glands. To explore and define the clinicopathological features of SP, we retrospectively analyzed 89 cases previously reported and five new cases.

methodsThe clinical features, histopathology, immunohistochemistry and molecular analysis of our cases were further performed and the related literatures were reviewed and analyzed.

resultsCombining 89 cases from the literature with our cases, the hard palate was the most common locations for SP. However, two of our cases were rarely located in the esophageal mucosa. Among all cases, the male gender was more affected, with the average age and median age of 61.8 and 62 years, respectively. Conventional histomorphologically, SP was characterized by complex papillary structures with a biphasic growth pattern of exophytic squamous component and endophytic glandular component. The glandular structures were lined by a double layer of epithelium composed of flattened or cuboidal basal cells and a cuboidal or columnar luminal cells formed papillary infoldings into the ductal lumina. Immunohistochemically, the luminal epithelial configurations showed strong expression of CK7 along the luminal cell membrane, while the basal myoepithelia displayed strong nuclear p63 expression. In both the glandular and squamous tumour components showed BRAF V600E-positive immunostaining and BRAF V600E mutation.

conclusionFor the first time, we have comprehensively aggregated and analyzed 90 cases sialadenoma papilliferum from almost all previous publications, and further explored the clinicopathological features of SP; concordantly, this study demonstrated that SP shows a papillomatous growth pattern with exophytic and endophytic proliferation of ductal epithelium composed of double-layered cells harboring BRAF V600E mutation. Additionly, adequate treatment for SP is surgical excision, with a favorable prognosis in patients.

Indexed as

AdultEpithelial CellsEpitheliumFemaleHumansImmunohistochemistryMaleMiddle AgedNeoplasms, Glandular and EpithelialPapillomaSalivary Gland NeoplasmsSalivary Glands, MinorBRAFClinical featuresHistopathologyImmunohistochemistrySialadenoma papilliferum

Identifiers

PMID33712056
PMCPMC7953575
OpenAlexW3134400465

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.